WVE EBITDA Growth
Wave Life Sciences Ltd · EBITDA Growth
WVE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-62.93%period ending
WVE TTM EBITDA YoY % (-285.49% → -62.93%)
Year-over-year change
High-resolution chart · PNG
WVE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -62.9348% | |
| -68.4002% | |
| -121.321% | |
| 15.4138% | |
| -89.3365% | |
| -99.2122% | |
| -85.4818% | |
| -80.6314% | |
| 46.9124% | |
| 62.9817% | |
| 68.4409% | |
| 47.9833% | |
| -9.6501% | |
| -30.779% | |
| -33.3089% | |
| -30.7049% | |
| 19.7577% | |
| 21.4701% | |
| 21.0476% | |
| 37.2615% | |
| 29.2159% | |
| 31.8276% | |
| 27.9847% | |
| 7.7283% | |
| -11.7873% | |
| -21.5771% | |
| -29.3448% | |
| -38.1775% | |
| -38.317% | |
| -44.6363% | |
| -54.7373% | |
| -54.437% | |
| -57.5064% | |
| -71.3698% | |
| -82.3992% | |
| -103.3472% | |
| -156.1097% | |
| -188.1308% | |
| -191.6114% | |
| -232.2865% | |
| -222.9401% | |
| -223.4545% | |
| -285.4905% |